Animalcare Group Plc (ANCR) - Net Assets
Based on the latest financial reports, Animalcare Group Plc (ANCR) has net assets worth GBX114.54 Million GBX (≈ $13.94K USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX158.10 Million ≈ $19.24K USD) and total liabilities (GBX43.56 Million ≈ $5.30K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check ANCR intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | GBX114.54 Million |
| % of Total Assets | 72.45% |
| Annual Growth Rate | 17.24% |
| 5-Year Change | 45.36% |
| 10-Year Change | 380.35% |
| Growth Volatility | 57.93 |
Animalcare Group Plc - Net Assets Trend (2000–2025)
This chart illustrates how Animalcare Group Plc's net assets have evolved over time, based on quarterly financial data. See operational self-sufficiency of Animalcare Group Plc to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Animalcare Group Plc (2000–2025)
The table below shows the annual net assets of Animalcare Group Plc from 2000 to 2025. For live valuation and market cap data, see Animalcare Group Plc (ANCR) total market value.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | GBX114.54 Million ≈ $13.94K |
+1.08% |
| 2024-12-31 | GBX113.31 Million ≈ $13.79K |
+45.47% |
| 2023-12-31 | GBX77.89 Million ≈ $9.48K |
-1.38% |
| 2022-12-31 | GBX78.99 Million ≈ $9.61K |
+0.24% |
| 2021-12-31 | GBX78.80 Million ≈ $9.59K |
-3.42% |
| 2020-12-31 | GBX81.59 Million ≈ $9.93K |
-0.36% |
| 2019-12-31 | GBX81.89 Million ≈ $9.96K |
-5.43% |
| 2018-12-31 | GBX86.59 Million ≈ $10.54K |
-3.40% |
| 2017-12-31 | GBX89.64 Million ≈ $10.91K |
+275.94% |
| 2017-06-30 | GBX23.84 Million ≈ $2.90K |
+5.91% |
| 2016-06-30 | GBX22.52 Million ≈ $2.74K |
+7.26% |
| 2015-06-30 | GBX20.99 Million ≈ $2.55K |
+7.91% |
| 2014-06-30 | GBX19.45 Million ≈ $2.37K |
+8.30% |
| 2013-06-30 | GBX17.96 Million ≈ $2.19K |
+6.68% |
| 2012-06-30 | GBX16.84 Million ≈ $2.05K |
+6.64% |
| 2011-06-30 | GBX15.79 Million ≈ $1.92K |
+12.13% |
| 2010-06-30 | GBX14.08 Million ≈ $1.71K |
-8.46% |
| 2009-06-30 | GBX15.38 Million ≈ $1.87K |
+5.03% |
| 2008-06-30 | GBX14.64 Million ≈ $1.78K |
+138.63% |
| 2007-06-30 | GBX6.14 Million ≈ $746.70 |
+5.48% |
| 2006-06-30 | GBX5.82 Million ≈ $707.88 |
+2.34% |
| 2005-06-30 | GBX5.68 Million ≈ $691.70 |
+20.52% |
| 2004-06-30 | GBX4.72 Million ≈ $573.92 |
+8.36% |
| 2003-06-30 | GBX4.35 Million ≈ $529.63 |
+14.61% |
| 2002-06-30 | GBX3.80 Million ≈ $462.11 |
+56.43% |
| 2001-06-30 | GBX2.43 Million ≈ $295.42 |
+22.32% |
| 2000-06-30 | GBX1.99 Million ≈ $241.52 |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Animalcare Group Plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4378.9% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | GBX13.81 Million | 12.06% |
| Other Components | GBX151.91 Million | 132.62% |
| Total Equity | GBX114.54 Million | 100.00% |
Animalcare Group Plc Competitors by Market Cap
The table below lists competitors of Animalcare Group Plc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
AIS Resources Ltd
V:AIS
|
$2.79 Million |
|
NorCom Information Technology GmbH & Co. KGaA
XETRA:NC5A
|
$2.79 Million |
|
Cottonindo Ariesta Tbk PT
JK:KPAS
|
$2.79 Million |
|
CBLT Inc
V:CBLT
|
$2.79 Million |
|
Ricky Putra Globalindo Tbk
JK:RICY
|
$2.78 Million |
|
COPPERCORP RESOURCES INC.
F:NU0
|
$2.78 Million |
|
Auddia Inc
NASDAQ:AUUD
|
$2.78 Million |
|
Mercator Limited
NSE:MERCATOR
|
$2.78 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Animalcare Group Plc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 113,312,000 to 114,540,000, a change of 1,228,000 (1.1%).
- Net income of 5,078,000 contributed positively to equity growth.
- Dividend payments of 3,587,000 reduced retained earnings.
- New share issuances of 14,000 increased equity.
- Other comprehensive income decreased equity by 2,089,999.
- Other factors increased equity by 1,812,999.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | GBX5.08 Million | +4.43% |
| Dividends Paid | GBX3.59 Million | -3.13% |
| Share Issuances | GBX14.00K | +0.01% |
| Other Comprehensive Income | GBX-2.09 Million | -1.82% |
| Other Changes | GBX1.81 Million | +1.58% |
| Total Change | GBX- | 1.08% |
Book Value vs Market Value Analysis
This analysis compares Animalcare Group Plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 201.00x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 3504.05x to 201.00x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2005-06-30 | GBX0.09 | GBX331.50 | x |
| 2006-06-30 | GBX0.10 | GBX331.50 | x |
| 2007-06-30 | GBX0.10 | GBX331.50 | x |
| 2008-06-30 | GBX0.24 | GBX331.50 | x |
| 2009-06-30 | GBX0.26 | GBX331.50 | x |
| 2010-06-30 | GBX0.23 | GBX331.50 | x |
| 2011-06-30 | GBX0.26 | GBX331.50 | x |
| 2012-06-30 | GBX0.28 | GBX331.50 | x |
| 2013-06-30 | GBX0.30 | GBX331.50 | x |
| 2014-06-30 | GBX0.32 | GBX331.50 | x |
| 2015-06-30 | GBX0.35 | GBX331.50 | x |
| 2016-06-30 | GBX0.37 | GBX331.50 | x |
| 2017-06-30 | GBX0.40 | GBX331.50 | x |
| 2017-12-31 | GBX1.49 | GBX331.50 | x |
| 2018-12-31 | GBX1.44 | GBX331.50 | x |
| 2019-12-31 | GBX1.36 | GBX331.50 | x |
| 2020-12-31 | GBX1.36 | GBX331.50 | x |
| 2021-12-31 | GBX1.31 | GBX331.50 | x |
| 2022-12-31 | GBX1.30 | GBX331.50 | x |
| 2023-12-31 | GBX1.28 | GBX331.50 | x |
| 2024-12-31 | GBX1.83 | GBX331.50 | x |
| 2025-12-31 | GBX1.65 | GBX331.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Animalcare Group Plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 4.43%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.70%
- • Asset Turnover: 0.56x
- • Equity Multiplier: 1.38x
- Recent ROE (4.43%) is below the historical average (6.09%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2005 | 4.93% | 3.71% | 1.12x | 1.18x | GBX-288.50K |
| 2006 | 3.49% | 2.59% | 1.01x | 1.34x | GBX-378.80K |
| 2007 | 4.07% | 3.01% | 1.10x | 1.23x | GBX-363.70K |
| 2008 | 6.10% | 7.60% | 0.47x | 1.70x | GBX-571.50K |
| 2009 | 6.75% | 5.89% | 0.70x | 1.65x | GBX-499.20K |
| 2010 | -7.32% | -9.19% | 0.49x | 1.64x | GBX-2.44 Million |
| 2011 | 14.73% | 19.66% | 0.63x | 1.19x | GBX746.10K |
| 2012 | 10.27% | 15.93% | 0.56x | 1.16x | GBX45.30K |
| 2013 | 10.49% | 15.56% | 0.56x | 1.20x | GBX88.80K |
| 2014 | 10.99% | 16.59% | 0.57x | 1.16x | GBX191.70K |
| 2015 | 12.07% | 18.72% | 0.55x | 1.17x | GBX434.90K |
| 2016 | 11.70% | 17.92% | 0.55x | 1.19x | GBX382.50K |
| 2017 | 10.36% | 15.57% | 0.55x | 1.21x | GBX85.50K |
| 2017 | 0.21% | 0.30% | 0.41x | 1.69x | GBX-8.78 Million |
| 2018 | -0.26% | -0.31% | 0.50x | 1.66x | GBX-8.88 Million |
| 2019 | -1.63% | -1.88% | 0.55x | 1.57x | GBX-9.53 Million |
| 2020 | 0.29% | 0.33% | 0.57x | 1.53x | GBX-7.93 Million |
| 2021 | -0.10% | -0.10% | 0.67x | 1.40x | GBX-7.96 Million |
| 2022 | 2.49% | 2.74% | 0.61x | 1.50x | GBX-5.93 Million |
| 2023 | 1.54% | 1.61% | 0.70x | 1.37x | GBX-6.59 Million |
| 2024 | 28.43% | 43.40% | 0.47x | 1.40x | GBX20.89 Million |
| 2025 | 4.43% | 5.70% | 0.56x | 1.38x | GBX-6.38 Million |
Industry Comparison
This section compares Animalcare Group Plc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $1,972,082,080
- Average return on equity (ROE) among peers: -41.76%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Animalcare Group Plc (ANCR) | GBX114.54 Million | 4.93% | 0.38x | $2.78 Million |
| Allergy Therapeutics (AGY) | $43.78 Million | 16.12% | 0.97x | $5.23 Million |
| Alliance Pharma plc (APH) | $2.24 Million | -3.15% | 0.01x | $4.26 Million |
| Celadon Pharmaceuticals PLC (CEL) | $6.41 Million | -74.61% | 0.03x | $112.25K |
| Chill Brands Group PLC (CHLL) | $2.11 Million | -387.19% | 0.58x | $168.61K |
| Eco Animal Health Group Plc (EAH) | $5.61 Million | 8.14% | 0.17x | $726.44K |
| HUTCHMED China Ltd (HCM) | $1.25 Billion | 36.57% | 0.40x | $16.58 Million |
| Hikma Pharmaceuticals PLC (HIK) | $48.03 Million | 21.86% | 0.98x | $39.26 Million |
| Haleon PLC (HLN) | $16.46 Billion | 6.44% | 1.12x | $361.92 Million |
| Indivior PLC (INDV) | $-66.00 Million | 0.00% | 0.00x | $18.79 Million |
About Animalcare Group Plc
Animalcare Group plc develops, sells, and distributes licensed veterinary pharmaceuticals for the companion animal, production animal, and equine veterinary markets in Europe, the Asia-Pacific, and internationally. It operates through Animalcare Europe and Randlab segments. The company offers Orozyme, an enzymatic toothpaste for dental care in cats and dogs; Danilon, an oral treatment for pain in… Read more